PCMag has been reviewing project management software since 2015. In addition to evaluating services based on ease of use, features, and value, we also consider what kinds of teams or projects work ...

PC hardware is nice, but it’s not much use without innovative software. I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo ...

The best video editing software, like the best free video editing software, helps you add post-production polish and create professional-looking. My team and I have reviewed the top apps and tools ...

What are the best Viking games on PC? The Vikings weren’t the most diplomatic group of settlers in history. The famous seafaring hustlers made haste across Northern Europe, causing chaos ...

SAN AN­TO­NIO — Promis­ing da­ta don’t al­ways equal a stock pop. Viking Ther­a­peu­tics pre­sent­ed what an­a­lysts thought were com­pelling da­ta on an oral … ...

Husqvarna announce all-new Pioneer electric-powered motorcycle to the enduro model range for 2025. “The perfect solution to recreational riding”? Husqvarna’s new electric motorcycle, the Pioneer, ...

SEE: Best Encryption Key Management Software (TechRepublic) Securing data both stored and in-transit through encryption is essential as part of an organization’s cybersecurity strategy.

Husqvarna has taken the covers off their new street-legal electric dirt bike, the Pioneer, running an MX50 5.5 kWh Li-Ion battery and offering up to 137 km of range (WMTC), or a run time of up to ...

Nov 4 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab shares reversed course to fall 8% on Monday as focus shifted to the drug developer's ability to mass produce its oral obesity ...

Getty Images Viking Therapeutics shares fell Monday after reporting the latest results from trials of its weight-loss drugs. Analysts say the treatment, which is being tested in both oral and ...

Viking Therapeutics is rowing its longboat toward the front of the oral obesity therapy race, posting detailed phase 1 data that suggest its dual agonist of GLP-1 and GIP can hold its own in a ...